Table 1.
Subject characteristics
| Crohn’s disease (n = 24) | Ulcerative colitis (n = 16) | Control group (n = 16) | P value | |
| Female, % | 54 | 56 | 50 | 0.902 |
| Age, yr | 31.0 ± 9.4 | 33.2 ± 21.9 | 30.3 ± 12.2 | 0.060 |
| BMI, kg/m2 | 21.4 ± 2.8 | 23.4 ± 5.6 | 22 ± 4.8 | 0.444 |
| Waist circumference, cm | 78.8 ± 9.9 | 78.4 ± 15.7 | 78.5 ± 8.5 | 0.090 |
| Hip circumference, cm | 91.5 ± 8.8 | 93.6 ± 11.9 | 91.1 ± 8.1 | 0.345 |
| Waist/hip ratio | 0.86 ± 0.08 | 0.84 ± 0.08 | 0.86 ± 0.07 | 0.472 |
| Duration of IBD, yr | 9.5 ± 7.9 | 10.5 ± 8.1 | - | 0.105 |
| Activity of IBD | - | |||
| CDAI | A: 241 ± 155 | - | ||
| B: 36.6 ± 25.3 | ||||
| Montreal severity classification | ||||
| S0/S1/S2/S3 | - | A: 0/1/14/1 | ||
| B: 8/8/0/0 | ||||
| Vienna classification | - | - | ||
| A1/A2 | 21/3 | |||
| L1/L2/L3/L4 | 2/5/17/0 | |||
| B1/B2/B3 | 14/6/4 |
A: Before treatment; B: 3 mo after initiation of treatment; CDAI: Crohn’s disease activity index; IBD: Inflammatory bowel disease; BMI: Body mass index.